Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohortKidney International, 2006
- RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patientsAtherosclerosis, 2005
- CCL2 Polymorphisms Are Associated With Serum Monocyte Chemoattractant Protein-1 Levels and Myocardial Infarction in the Framingham Heart StudyCirculation, 2005
- Proinflammatory Genetic Profiles in Subjects With History of Ischemic StrokeStroke, 2004
- Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patientsHemodialysis International, 2004
- Hypertension and cardiovascular risk assessment in dialysis patientsNephrology Dialysis Transplantation, 2004
- Association between a Single-Nucleotide Polymorphism in the Promoter of the Human Interleukin-3 Gene and Rheumatoid Arthritis in Japanese Patients, and Maximum-Likelihood Estimation of Combinatorial Effect That Two Genetic Loci Have on Susceptibility to the DiseaseThe American Journal of Human Genetics, 2001
- Increase in Circulating Levels of Monocyte Chemoattractant Protein-1 with AgingJournal of Interferon & Cytokine Research, 1999
- A Novel Polymorphism in the MCP-1 Gene Regulatory Region That Influences MCP-1 ExpressionBiochemical and Biophysical Research Communications, 1999
- Chemokine Receptor CCR2 Expression and Monocyte Chemoattractant Protein-1–Mediated Chemotaxis in Human MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 1998